Literature DB >> 1516714

A selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulfonamide (H-89), inhibits phosphatidylcholine biosynthesis in HeLa cells.

C C Geilen1, M Wieprecht, T Wieder, W Reutter.   

Abstract

In this study, we report that the potent and selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulfonamide (H-89) interferes with the incorporation of choline into phosphatidylcholine in HeLa cells. Treatment of cells with 10 microM H-89 for 1 h decreases the phosphatidylcholine biosynthesis by 50%. This inhibition is prevented by simultaneous addition of 10 microM forskolin, while the choline uptake itself is not affected by H-89.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516714     DOI: 10.1016/0014-5793(92)80811-t

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Protein kinase A activation increases sodium current magnitude in the electric organ of Sternopygus.

Authors:  L McAnelly; H H Zakon
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

2.  Tri-iodothyronine induces hepatocyte proliferation by protein kinase A-dependent β-catenin activation in rodents.

Authors:  Maura Fanti; Sucha Singh; Giovanna M Ledda-Columbano; Amedeo Columbano; Satdarshan P Monga
Journal:  Hepatology       Date:  2014-04-14       Impact factor: 17.425

3.  Roles for interleukin-1beta, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression.

Authors:  X Zhou; P Polgar; L Taylor
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Differential regulation of the high affinity choline transporter and the cholinergic locus by cAMP signaling pathways.

Authors:  Martina Brock; Ann-Christin Nickel; Beata Madziar; Jan Krzysztof Blusztajn; Brygida Berse
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

6.  Cellular pathways involved in the ex vivo expression of bovine leukemia virus.

Authors:  P Kerkhofs; E Adam; L Droogmans; D Portetelle; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

8.  Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.

Authors:  R A Armstrong
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulphonamide (H-89) inhibits incorporation of choline into phosphatidylcholine via inhibition of choline kinase and has no effect on the phosphorylation of CTP:phosphocholine cytidylyltransferase.

Authors:  M Wieprecht; T Wieder; C C Geilen
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

10.  Desensitization of the mu-opioid activation of phospholipase C in SH-SY5Y cells: the role of protein kinases C and A and Ca(2+)-activated K+ currents.

Authors:  D Smart; D G Lambert
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.